Sarcoglycanopathies

Sarcoglycanopathies are a group of rare genetic diseases. They happen when there's a problem with the genes that make proteins called sarcoglycans. These proteins are important for muscle function. When they don't work properly, it can lead to muscle weakness, problems with the heart, and breathing difficulties. There are different types, some are inherited and some are caused by new changes in the genes.

Condition

What people with Sarcoglycanopathies report

Every report comes from a Lived member, sent anonymously.

Have you tried Occupational Therapy for Sarcoglycanopathies?

NameHow it went

About Sarcoglycanopathies

What It Is

Sarcoglycanopathies are a group of inherited muscle diseases that belong to the limb-girdle muscular dystrophies. They mainly weaken the muscles around the hips and shoulders, so early signs are often trouble running, climbing stairs or getting up from the floor, walking on the toes, and shoulder blades that stick out from the back. Many people also have enlarged calf muscles. Over time the weakness spreads, and in many people it eventually affects the heart and the muscles used for breathing. The name comes from the sarcoglycans, a set of four proteins (alpha, beta, gamma and delta) that help hold the outer membrane of each muscle fiber together. When one of them is missing or faulty, muscle fibers are damaged by ordinary use and are gradually replaced by fat and scar tissue. Each protein gives its name to a subtype, also known by an older and a newer code: alpha-sarcoglycanopathy (LGMD2D, now LGMDR3), beta (LGMD2E, LGMDR4), gamma (LGMD2C, LGMDR5) and delta (LGMD2F, LGMDR6). The conditions are rare, and symptoms usually begin in childhood, though milder forms can start later.

Causes & Risk Factors

Sarcoglycanopathies are genetic. They are caused by changes in one of four genes (SGCA, SGCB, SGCG or SGCD), each of which carries the instructions for one sarcoglycan protein. Nothing a person or parent did causes the condition, and infections, injuries or lifestyle do not start it, although an illness can temporarily make weakness worse. The inheritance pattern is autosomal recessive. A person develops the condition only when both copies of the gene carry a change, one from each parent. Parents are usually healthy carriers with no symptoms, which is why a child can be the first person in a family to be affected. When both parents are carriers, each pregnancy has a 1 in 4 chance of an affected child. The condition is more common in families or communities where parents are related to each other, and some subtypes cluster in particular regions.

How It's Diagnosed

Diagnosis usually starts with a neurologist or neuromuscular specialist examining which muscles are weak and how the person moves. A blood test for creatine kinase (CK), an enzyme that leaks out of damaged muscle, is almost always high, often more than five times the upper limit of normal. A high CK shows that muscle is being damaged, but it does not say why. Genetic testing confirms the diagnosis by finding changes in both copies of one sarcoglycan gene. Testing usually uses a panel that checks many muscle disease genes at once, because several other conditions look similar, including Duchenne and Becker muscular dystrophy and other limb-girdle types. Sometimes the result is unclear: only one change is found, or a change is labeled a variant of uncertain significance, meaning its effect is not yet known. In that case, an MRI of the muscles can show a typical pattern of affected and spared muscles, and a muscle biopsy can show whether the sarcoglycan proteins are reduced. Once the diagnosis is made, a baseline heart and breathing assessment is part of the workup.

Treatment Options

There is currently no treatment that corrects the underlying protein problem, so care focuses on keeping people strong, mobile and safe for as long as possible. This works best with a team that may include a neuromuscular specialist, physical and occupational therapists, a cardiologist and a lung specialist. Physical therapy starts soon after diagnosis. Regular stretching, night splints or braces that hold the ankles and knees in position, and gentle exercise help keep joints flexible and slow the tightening of tendons (contractures). Low-impact, moderate activity such as water-based exercise is generally encouraged, but intense or strenuous exercise can cause rapid muscle breakdown, so staying well hydrated and stopping before exhaustion matter. Mobility aids, adapted equipment and, when needed, a wheelchair help preserve independence. Surgery may be considered for a curved spine (scoliosis) or severe contractures. Heart and breathing care are central because problems often develop without symptoms. An echocardiogram (an ultrasound of the heart) and an electrocardiogram (ECG, a recording of the heart's rhythm) are recommended at least once a year from diagnosis. If the heart muscle weakens, standard heart failure medicines such as ACE inhibitors, beta-blockers and diuretics are used, and a pacemaker or, rarely, a heart transplant may be needed. Breathing tests measure forced vital capacity, how much air a person can blow out after a full breath. As this falls, overnight oxygen monitoring checks for shallow breathing during sleep, and a mask-based breathing machine worn at night (non-invasive ventilation) can improve quality of life and survival. Cough-assist devices help clear the chest, and yearly flu vaccination and early treatment of chest infections are recommended. Corticosteroids such as prednisolone or deflazacort, used in Duchenne muscular dystrophy, have shown possible benefit in small reports but are not an established treatment for sarcoglycanopathies. Gene therapy, which uses a modified virus to deliver a working copy of the missing gene, is being tested in clinical trials for some subtypes, especially beta-sarcoglycanopathy. Early results are encouraging but these treatments remain experimental, and their long-term benefits and risks are still being studied.

What to Expect

The course varies more than with many muscle diseases, even within the same subtype. In the typical severe form, weakness starts in the first decade, progresses steadily, and many people lose the ability to walk during their teens, with heart and breathing involvement developing around the same time. Gamma, beta and delta forms more often follow this pattern, and heart problems are most frequent with beta and delta. Alpha-sarcoglycanopathy is often milder but ranges widely, from a high CK found by chance to Duchenne-like disease. People with milder forms may first notice symptoms after age 10 and progress slowly, sometimes walking well into adulthood. In general, the more working sarcoglycan protein the muscles still make, the milder the condition. Hand and face muscles are usually spared, and thinking and learning are generally not affected, so many people continue school, work and relationships with practical adjustments. Daily life tends to involve planning around stairs, distance and fatigue, and later around wheelchair access, transfers and personal care. Regular reviews track strength, heart and breathing so that treatment can start before problems become serious. Because information about the natural course is still limited, registries and natural history studies are an important way families contribute to research and learn about trials.

When to Seek Help

See a doctor for an assessment if a child or adult has persistent difficulty running, climbing stairs or rising from the floor, toe-walking, enlarged calves, or a high CK found on a blood test, especially if there is a family history of muscle disease. Genetic counseling is worthwhile for relatives and for anyone planning a pregnancy. Contact the care team promptly about new or worsening breathlessness, swelling of the legs, palpitations or fainting, which can signal heart involvement, and about morning headaches, daytime sleepiness or poor sleep, which can mean breathing is weakening at night. A chest infection also needs early treatment when breathing muscles are weak. Dark, red or cola-colored urine, or severe muscle pain and weakness after exertion, can mean rapid muscle breakdown that can harm the kidneys, and needs medical attention right away.

Questions to Ask Your Doctor

  1. 1.Which subtype do I or my child have, and what does that suggest about how the condition is likely to progress?
  2. 2.How often should the heart and breathing be checked, and which results would change treatment?
  3. 3.What kinds and amounts of exercise are safe, and what signs mean I am overdoing it?
  4. 4.Should other family members have carrier testing or genetic counseling?
  5. 5.Are there registries, natural history studies or gene therapy trials we could be eligible for?

Last reviewed • Oct 2026

Educational content, not medical advice.